Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Oral vs Prolonged IV Furosemide in Decompensated Heart Failure
NCT05652322Phase 3Withdrawn
- Sponsor
- Jan Kochanowski University
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of furosemide in heart failure (HF), sponsored by Jan Kochanowski University. Planned start Dec 2022; status: withdrawn.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05652322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05652322.